Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice

University Hospital of Lausanne, Lausanne, Vaud, Switzerland
Toxicologic Pathology (Impact Factor: 1.92). 01/2005; 33(3):307-12. DOI: 10.1080/01926230590922848
Source: PubMed

ABSTRACT The nervous system of the B6C3F1 mouse has rarely been a target for chemical carcinogenesis in the National Toxicology Program (NTP) bioassays. However, 6 malignant gliomas and 2 neuroblastomas were observed in B6C3F1 mice exposed to 625 ppm 1,3-butadiene (NTP technical reports 288 and 434). These mouse brain tumors were evaluated with regard to the profile of genetic alterations that are observed in human brain tumors. Alterations in the p53 tumor suppressor gene were common. Missense mutations were observed in 3/6 malignant gliomas and 2/2 neuroblastomas and were associated with loss of heterozygosity. Most of the mutations occurred in exons 5-8 of the p53 gene and were G-->A transitions, and did not involve CpG sites. Loss of heterozygosity at the Ink4a/Arf gene locus was observed in 5/5 malignant gliomas and 1/1 neuroblastoma, while the PTEN(phosphatase and tensin homologue) gene locus was unaffected by deletions. One of 2 neuroblastomas had a mutation in codon 61 of H-ras, while H-ras mutations were not observed in the malignant gliomas examined. Only 1 brain tumor has been reported from control mice of over 500 NTP studies. This malignant glioma showed no evidence of alterations in the p53 gene or K- and H-ras mutations. It is likely that the specific genetic alterations observed were induced or selected for by 1,3-butadiene treatment that contributed to the development of mouse brain tumors. The observed findings are similar in part to the genetic alterations reported in human brain tumors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: KeywordsBase Substitution Mutations–Frameshift Mutations–Deletion Mutations–DNA Crosslinks–DNA Repair–Transgenic Mice– Hprt Mutations–TK6 Human Lymphoblastoid Cells– Salmonella typhimurium
    12/2007: pages 1-31;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Age-adjusted brain cancer rates vary more than fourfold among US counties, but risk factors underlying this variation have not been identified. The only known risk factor for brain cancer is ionizing radiation at therapeutic dose levels. Lifestyle factors are not known to affect brain cancer risk; hypothetical risks from environmental or occupational exposures to numerous chemicals have been suggested, but no consistent results have emerged in populations exposed to chemicals via oral intake or inhalation. We investigated whether county-by-county brain cancer incidence rates and mortality rates were correlated with patterns of local ambient air pollution. We utilized central-site ambient measurement data for criteria air pollutants, and inhalation exposure concentrations of hazardous air pollutants (HAPs) as predicted by the US EPA National Air Toxics Assessment. We selected 30 HAPs that had been variously hypothesized in the context of a link to brain cancer risk. We also included a regression on density of domestic cattle populations given that viruses have been implicated in brain cancer and cattle are a well-known reservoir for a variety of viruses. The analyses yielded correlations that were mostly null or negative, with similar results obtained for brain cancer incidence and mortality rates. The cattle density correlations were slightly positive and statistically significant. Given the limitations of this exploratory analysis, further research is needed to investigate the role of environmental chemical exposures in brain cancer risk. Our findings suggest that county-by-county differences in air pollution exposure concentrations are not likely to be explanatory factors for variations in brain cancer rates.
    Air Quality Atmosphere & Health 01/2012; 5(1). DOI:10.1007/s11869-010-0122-3 · 1.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: 1,3-Butadiene (BD) is a multisite carcinogen in laboratory rodents following lifetime exposure, with greater potency in the mouse than the rat, and is associated with an increase in leukemia mortality in highly exposed workers. Species differences in the formation of reactive metabolites underlie observed species differences in sensitivity to the carcinogenic effects of BD. The modes of action (MOAs) for human leukemia and rodent tumors are both likely related to mutagenic potencies of one or more of these metabolites. However, differences in the nature of genotoxic lesions associated with human leukemia and rodent tumors, along with their implications for risk assessment, require that they be discussed separately. The MOAs for BD are assessed in this review using the modified Hill criteria and human relevance framework. Key events in MOAs for human and rodent cancers are identified, along with important species differences and sources of nonlinearity for each event that can affect extrapolations made from high- to low-dose exposures. Because occupational exposures to BD have also included co-exposures to styrene and dimethyldithiocarbamide (DMDTC), potential interactions with BD carcinogenicity are also discussed. The MOAs for BD carcinogenesis will be used to guide key decisions made in the quantitative cancer dose-response assessment.
    Critical Reviews in Toxicology 10/2010; 40 Suppl 1(S1):74-92. DOI:10.3109/10408444.2010.507183 · 6.41 Impact Factor

Full-text (2 Sources)

Available from
Oct 16, 2014